The Cardiovascular Research Foundation (CRF) has announced that over 30 late-breaking trial and science presentations that will be reported at TCT Connect (14–18 October, Virtual). TCT Connect is the the annual scientific symposium of CRF and specialises in interventional cardiovascular medicine.
“Every year, TCT features major medical research breakthroughs that directly impact patient care, and this year is no different,” said Juan F Granada, president and chief executive officer of CRF. “Data from these trials will impact how physicians treat heart disease by helping them improve and refine procedures and identifying the types of patients who would benefit most from treatment.”
The studies selected examine the safety and effectiveness of minimally invasive techniques, pharmaceuticals, technologies, and devices that demonstrate potential to treat or prevent cardiovascular disease. Late-breaking trials and science will be presented on the Main Arena. This year’s TCT Connect also includes a special endovascular late-breaking session.